IL220009A - Indole compounds, preparations containing them and their uses - Google Patents

Indole compounds, preparations containing them and their uses

Info

Publication number
IL220009A
IL220009A IL220009A IL22000912A IL220009A IL 220009 A IL220009 A IL 220009A IL 220009 A IL220009 A IL 220009A IL 22000912 A IL22000912 A IL 22000912A IL 220009 A IL220009 A IL 220009A
Authority
IL
Israel
Prior art keywords
compositions
same
indole compounds
indole
compounds
Prior art date
Application number
IL220009A
Other languages
English (en)
Hebrew (he)
Other versions
IL220009A0 (en
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of IL220009A0 publication Critical patent/IL220009A0/en
Publication of IL220009A publication Critical patent/IL220009A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL220009A 2009-11-25 2012-05-24 Indole compounds, preparations containing them and their uses IL220009A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009268040 2009-11-25
PCT/JP2010/070988 WO2011065402A1 (ja) 2009-11-25 2010-11-25 インドール化合物及びその医薬用途

Publications (2)

Publication Number Publication Date
IL220009A0 IL220009A0 (en) 2012-07-31
IL220009A true IL220009A (en) 2017-08-31

Family

ID=44066507

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220009A IL220009A (en) 2009-11-25 2012-05-24 Indole compounds, preparations containing them and their uses

Country Status (31)

Country Link
US (6) US8299070B2 (cg-RX-API-DMAC7.html)
EP (3) EP2505586B1 (cg-RX-API-DMAC7.html)
JP (6) JP5734628B2 (cg-RX-API-DMAC7.html)
KR (1) KR101766502B1 (cg-RX-API-DMAC7.html)
CN (1) CN102712624B (cg-RX-API-DMAC7.html)
AR (1) AR079164A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010323579C1 (cg-RX-API-DMAC7.html)
BR (1) BR112012012529B1 (cg-RX-API-DMAC7.html)
CA (1) CA2781660C (cg-RX-API-DMAC7.html)
CL (1) CL2012001328A1 (cg-RX-API-DMAC7.html)
CO (1) CO6541645A2 (cg-RX-API-DMAC7.html)
CY (1) CY1117559T1 (cg-RX-API-DMAC7.html)
DK (1) DK2505586T3 (cg-RX-API-DMAC7.html)
ES (1) ES2572935T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20160579T1 (cg-RX-API-DMAC7.html)
HU (1) HUE028016T2 (cg-RX-API-DMAC7.html)
IL (1) IL220009A (cg-RX-API-DMAC7.html)
ME (1) ME02447B (cg-RX-API-DMAC7.html)
MX (1) MX2012006017A (cg-RX-API-DMAC7.html)
MY (1) MY161095A (cg-RX-API-DMAC7.html)
NZ (1) NZ600840A (cg-RX-API-DMAC7.html)
PE (1) PE20121358A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012501021A1 (cg-RX-API-DMAC7.html)
PL (1) PL2505586T3 (cg-RX-API-DMAC7.html)
PT (1) PT2505586E (cg-RX-API-DMAC7.html)
RS (1) RS54910B1 (cg-RX-API-DMAC7.html)
RU (1) RU2556216C2 (cg-RX-API-DMAC7.html)
SI (1) SI2505586T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201600258B (cg-RX-API-DMAC7.html)
TW (1) TWI491591B (cg-RX-API-DMAC7.html)
WO (1) WO2011065402A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
MX342405B (es) 2010-06-03 2016-09-28 Pharmacyclics Inc El uso de inhibidores de la tirosina quinasa de bruton (btk).
BR112015001690A2 (pt) 2012-07-24 2017-11-07 Pharmacyclics Inc mutações associadas com a resistência a inibidores da tirosina quinase de bruton (btk)
CA2890111A1 (en) 2012-11-02 2014-05-08 Pharmacyclics, Inc. Tec family kinase inhibitor adjuvant therapy
CN103804364A (zh) * 2012-11-06 2014-05-21 韩冰 一类治疗缺血性脑损伤的化合物及其用途
CN103800337A (zh) * 2012-11-07 2014-05-21 韩冰 一类治疗神经退行性疾病的化合物及其用途
CN103800328A (zh) * 2012-11-07 2014-05-21 韩冰 一类治疗神经退行性疾病的化合物及其用途
CN103804361A (zh) * 2012-11-07 2014-05-21 韩冰 一类治疗神经退行性疾病的化合物及其用途
CN103804291A (zh) * 2012-11-07 2014-05-21 韩冰 一类治疗神经退行性疾病的化合物及其用途
CN103800340A (zh) * 2012-11-09 2014-05-21 韩冰 一类治疗青光眼的化合物及其用途
CN103804351A (zh) * 2012-11-14 2014-05-21 韩冰 一类具有神经保护作用的化合物及其用途
CN103804363A (zh) * 2012-11-14 2014-05-21 韩冰 一类具有神经保护作用的化合物及其用途
CN103804302A (zh) * 2012-11-14 2014-05-21 杨育新 一类治疗创伤性脑损伤疾病的化合物及其用途
CN103804272A (zh) * 2012-11-14 2014-05-21 韩冰 一类具有神经保护作用的化合物及其用途
CN104628657A (zh) * 2013-11-06 2015-05-20 韩冰 一类治疗缺血性脑损伤的化合物及其用途
JP2017509336A (ja) 2014-03-20 2017-04-06 ファーマサイクリックス エルエルシー ホスホリパーゼｃガンマ２及び耐性に関連した変異
AR099936A1 (es) * 2014-04-04 2016-08-31 Sanofi Sa Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
ES2748324T3 (es) * 2014-07-04 2020-03-16 Japan Tobacco Inc Método para producir un compuesto de indol
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
CN104356086A (zh) * 2014-11-28 2015-02-18 湖南科技大学 一种适于工业生产3-吗啉酮的制备方法
CN112118843B (zh) * 2018-05-25 2023-09-29 日本烟草产业株式会社 使用吲哚化合物治疗疼痛或间质性膀胱炎的方法
JP7322007B2 (ja) * 2018-05-25 2023-08-07 日本たばこ産業株式会社 インドール化合物を含むネフローゼ症候群の治療又は予防剤
JP7407705B2 (ja) * 2018-05-25 2024-01-04 日本たばこ産業株式会社 インドール化合物を含む多発性硬化症の治療又は予防剤
IL293831B2 (en) 2019-12-20 2024-02-01 Pfizer Benzimidazole derivatives
KR102270026B1 (ko) * 2020-01-31 2021-06-28 현대약품 주식회사 (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
US20240132477A1 (en) * 2020-12-15 2024-04-25 Pfizer Inc. Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease
US20240124439A1 (en) * 2020-12-15 2024-04-18 Pfizer Inc. Pyrido[2,3-D]Imidazole Derivatives and Their Use As Inhibitors of ITK for the Treatment of Skin Disease
US20240279202A1 (en) * 2021-05-03 2024-08-22 Nurix Therapeutics, Inc. Compounds for inhibiting or degrading itk, compositions, comprising the same methods of their making and methods of their use
CA3217892A1 (en) * 2021-05-03 2022-11-10 Joel Mcintosh Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their use
TW202315618A (zh) * 2021-06-11 2023-04-16 美商愛德亞生物科學公司 作為DNA聚合酶θ抑制劑之O-聯結噻二唑基化合物
AU2022370351A1 (en) * 2021-10-19 2024-05-02 Nurix Therapeutics, Inc. Bifunctional compounds for degrading itk via ubiquitin proteosome pathway
KR20250166329A (ko) * 2023-04-13 2025-11-27 다나틀라스 파마슈티컬즈 씨오., 엘티디. 티아디아졸론 유도체 및 이의 조성물과 응용

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US953411A (en) * 1908-09-02 1910-03-29 Erastus De Moulin Trick weight-lifting machine.
BR0213562A (pt) * 2001-10-26 2004-08-31 Aventis Pharma Inc Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna
DK1474425T3 (da) * 2002-01-07 2006-09-25 Eisai Co Ltd Deazapuriner og anvendelser deraf
JP2003231687A (ja) 2002-02-04 2003-08-19 Japan Tobacco Inc ピラゾリル縮合環化合物及びその医薬用途
FR2854159B1 (fr) * 2003-04-25 2008-01-11 Aventis Pharma Sa Nouveaux derives de l'indole, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de kdr
US20050032869A1 (en) * 2003-07-08 2005-02-10 Pharmacia Italia S.P.A. Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2005026175A1 (en) * 2003-09-08 2005-03-24 Aventis Pharmaceuticals Inc. Thienopyrazoles
EP1880993A4 (en) * 2005-04-19 2009-12-30 Kyowa Hakko Kirin Co Ltd NITROGENIC HETEROCYCLIC COMPOUND
EP1968580A2 (en) 2005-12-20 2008-09-17 Boehringer Ingelheim International Gmbh 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
GB0602178D0 (en) * 2006-02-03 2006-03-15 Merck Sharp & Dohme Therapeutic treatment
MX2008012482A (es) * 2006-03-31 2008-10-10 Abbott Lab Compuestos de indazol.
AU2007254179B2 (en) * 2006-05-18 2013-03-21 Pharmacyclics Llc Intracellular kinase inhibitors
EP2108642A1 (en) * 2006-10-17 2009-10-14 Kyowa Hakko Kirin Co., Ltd. Jak inhibitor
EP2081892A4 (en) 2006-11-17 2014-03-05 Donald F Weaver COMPOUNDS AND METHOD FOR THE TREATMENT OF PROTEIN DISAPPEARANCE
UA99459C2 (en) 2007-05-04 2012-08-27 Астразенека Аб 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
JP2009268040A (ja) 2008-04-23 2009-11-12 Teruhiko Daiho ループアンテナ装置
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof

Also Published As

Publication number Publication date
CA2781660C (en) 2018-06-26
PE20121358A1 (es) 2012-10-23
ME02447B (me) 2016-09-20
US20130116240A1 (en) 2013-05-09
ES2572935T3 (es) 2016-06-03
JP2021091718A (ja) 2021-06-17
CN102712624A (zh) 2012-10-03
IL220009A0 (en) 2012-07-31
CO6541645A2 (es) 2012-10-16
NZ600840A (en) 2014-01-31
HUE028016T2 (en) 2016-11-28
SMT201600258B (it) 2016-08-31
TW201124378A (en) 2011-07-16
JP2015172051A (ja) 2015-10-01
CY1117559T1 (el) 2017-04-26
AR079164A1 (es) 2011-12-28
US20180362506A1 (en) 2018-12-20
JP5734628B2 (ja) 2015-06-17
AU2010323579C1 (en) 2016-11-03
DK2505586T3 (en) 2016-05-30
PH12012501021A1 (en) 2013-01-14
CA2781660A1 (en) 2011-06-03
JP2017039761A (ja) 2017-02-23
KR101766502B1 (ko) 2017-08-08
EP3059234A1 (en) 2016-08-24
CL2012001328A1 (es) 2012-10-05
BR112012012529B1 (pt) 2021-10-26
RS54910B1 (sr) 2016-10-31
EP3766877A1 (en) 2021-01-20
MY161095A (en) 2017-04-14
RU2556216C2 (ru) 2015-07-10
KR20120096540A (ko) 2012-08-30
MX2012006017A (es) 2012-06-25
JP2011132222A (ja) 2011-07-07
AU2010323579A1 (en) 2012-07-19
PT2505586E (pt) 2016-06-03
BR112012012529A2 (pt) 2016-05-03
EP2505586A4 (en) 2013-05-15
JP2018158935A (ja) 2018-10-11
PL2505586T3 (pl) 2016-12-30
EP2505586A1 (en) 2012-10-03
TWI491591B (zh) 2015-07-11
US20170267662A1 (en) 2017-09-21
US20110306599A1 (en) 2011-12-15
AU2010323579B2 (en) 2016-05-19
HRP20160579T1 (hr) 2016-07-29
EP2505586B1 (en) 2016-03-02
SI2505586T1 (sl) 2016-08-31
CN102712624B (zh) 2014-06-04
US8299070B2 (en) 2012-10-30
US20210284627A1 (en) 2021-09-16
HK1174025A1 (en) 2013-05-31
WO2011065402A1 (ja) 2011-06-03
RU2012126129A (ru) 2013-12-27
JP2020079276A (ja) 2020-05-28
US20200255408A1 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
IL220009A0 (en) Indole compounds, compositions comprising the same and uses thereof
IL220625A (en) Isoindolinone compounds, preparations containing them and their uses
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
IL241634A0 (en) History of benzodiazepines, preparations containing them and their uses
IL217541A0 (en) Triazolopyridine compounds, compositions comprising the same and uses thereof
IL216254A (en) Compounds, pharmaceutical compositions and their uses
AP2012006314A0 (en) Antiparistic dihydroazole compounds and compositions comprising same.
IL208220A0 (en) Substituted imidazoquinolines, compositions comprising the same and uses thereof
IL220563A0 (en) Pteridinone compounds, compositions comprising the same and uses thereof
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
IL221210A0 (en) Heterocyclic compounds, compositions comprising the same and uses thereof
IL216833A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
IL216829A0 (en) Ureidophenyl substituted triazine derivatives, compositions comprising the same and uses thereof
IL210722A0 (en) Benzazepine derivatives, compositions comprising the same and uses thereof
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
EP2282735A4 (en) COMPOUNDS, COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
IL216827A0 (en) Benzyl substituted triazine derivatives, compositions comprising the same and uses thereof
IL219243A (en) History of 5-hydroxypyrimidine-4-carboxamide, preparations containing them and their uses
IL223405B (en) Phosphoplatins, preparations containing them and their uses
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
IL216828A0 (en) Styryl-triazine derivatives, compositions comprising the same and uses thereof
IL216462A0 (en) Nitrile derivatives, compositions comprising the same and uses thereof
IL218331A0 (en) Tetrahydroisoquinoline compounds, compositions comprising the same and uses thereof
IL216581A0 (en) Aminopyrazole triazolothiadiazole compounds, compositions comprising the same and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed